161 related articles for article (PubMed ID: 15495345)
1. Is intraneuronal amyloid beta-peptide accumulation the trigger of Alzheimer's disease pathophysiology?
Moreira PI; Liu Q; Honda K; Smith MA; Santos MS; Oliveira CR
J Alzheimers Dis; 2004 Aug; 6(4):433-4; discussion 443-9. PubMed ID: 15495345
[No Abstract] [Full Text] [Related]
2. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
3. Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
Nunomura A; Tamaoki T; Tanaka K; Motohashi N; Nakamura M; Hayashi T; Yamaguchi H; Shimohama S; Lee HG; Zhu X; Smith MA; Perry G
Neurobiol Dis; 2010 Mar; 37(3):731-7. PubMed ID: 20034567
[TBL] [Abstract][Full Text] [Related]
4. A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta.
Hilt S; Altman R; Kálai T; Maezawa I; Gong Q; Wachsmann-Hogiu S; Jin LW; Voss JC
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103547
[TBL] [Abstract][Full Text] [Related]
5. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
Nagele RG; D'Andrea MR; Anderson WJ; Wang HY
Neuroscience; 2002; 110(2):199-211. PubMed ID: 11958863
[TBL] [Abstract][Full Text] [Related]
6. Alternative hypotheses related to Alzheimer's disease.
Cubinkova V; Valachova B; Uhrinova I; Brezovakova V; Smolek T; Jadhav S; Zilka N
Bratisl Lek Listy; 2018; 119(4):210-216. PubMed ID: 29663818
[TBL] [Abstract][Full Text] [Related]
7. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
8. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease.
Butterfield DA; Howard B; Yatin S; Koppal T; Drake J; Hensley K; Aksenov M; Aksenova M; Subramaniam R; Varadarajan S; Harris-White ME; Pedigo NW; Carney JM
Life Sci; 1999; 65(18-19):1883-92. PubMed ID: 10576432
[TBL] [Abstract][Full Text] [Related]
9. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
Matsuoka Y; Picciano M; La Francois J; Duff K
Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
[TBL] [Abstract][Full Text] [Related]
11. Intracellular amyloid beta-protein and its associated molecules in the pathogenesis of Alzheimer's disease.
Ohyagi Y; Tabira T
Mini Rev Med Chem; 2006 Oct; 6(10):1075-80. PubMed ID: 17073707
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
Cioffi F; Adam RHI; Broersen K
J Alzheimers Dis; 2019; 72(4):981-1017. PubMed ID: 31744008
[TBL] [Abstract][Full Text] [Related]
13. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid beta-peptide (1-42).
Butterfield DA; Yatin SM; Link CD
Ann N Y Acad Sci; 1999; 893():265-8. PubMed ID: 10672245
[No Abstract] [Full Text] [Related]
15. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
Butterfield DA
Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
[TBL] [Abstract][Full Text] [Related]
16. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
[TBL] [Abstract][Full Text] [Related]
17. Clathrin-mediated endocytosis and Alzheimer's disease: an update.
Wu F; Yao PJ
Ageing Res Rev; 2009 Jul; 8(3):147-9. PubMed ID: 19491039
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of Bcl-xL in response to subtoxic beta-amyloid: role in neuronal resistance against apoptotic and oxidative injury.
Luetjens CM; Lankiewicz S; Bui NT; Krohn AJ; Poppe M; Prehn JH
Neuroscience; 2001; 102(1):139-50. PubMed ID: 11226677
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
Yatin SM; Varadarajan S; Link CD; Butterfield DA
Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
[TBL] [Abstract][Full Text] [Related]
20. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
